NPAS2 Deficiency Leads to Antidepressant‐Like Behaviors in Mice by Modulating Astrocyte‐Mediated Neuroinflammation
Journal of Pineal Research · 2025
DOI: 10.1111/jpi.70070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pineal Research, 2025. Verfasst von Yiyuan Tian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Astrocytes, Basic Helix-Loop-Helix Proteins, Neuroinflammatory Diseases, Depression. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: This study was supported by the China Postdoctoral Science Foundation funded project (grant 2019M663984 and 2020T130787) and National Science Basic Research Pl….
Abstract (Originalsprache)
Major Depressive Disorder (MDD) is closely associated with neuroinflammation, but the underlying mechanisms remain to be fully elucidated. This study investigates the role of NPAS2 in mediating neuroinflammation‐induced depressive‐like behaviors using NPAS2 knockout (KO) mice and lipopolysaccharide (LPS) treatment. We confirmed that NPAS2 protein expression in the hippocampus was significantly increased in mice exposed to LPS or chronic unpredictable mild stress (CUMS). Moreover, in the hippocampus, NPAS2 in astrocytes is more sensitive to inflammatory stimuli than that in neurons. NPAS2 KO mice demonstrated attenuated astrocyte activation, reduced neuroinflammation associated with the inhibition of NF‐κB and JAK2/STAT3 signaling pathways, and resilience to depressive‐ and anxiety‐like behaviors. Mechanistically, the antidepressant effects in NPAS2 KO mice were mediated through the BDNF/TrkB signaling pathway, which is regulated by inflammatory factors and controls synaptic plasticity. This conclusion was supported by the reversal of these effects using the BDNF receptor antagonist k252a. These findings highlight the critical role of astrocytic NPAS2 in mediating neuroinflammation‐induced depressive‐like behaviors and suggest that targeting NPAS2 may represent a novel therapeutic strategy for MDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
- Department of Interventional Radiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
- Department of Hematology, Xi'an Central Hospital, Xi'an, Shaanxi, China.
- First Clinical Medical College, Shaanxi University of Chinese Medicine, Xi'an, Shaanxi, China.
- Precision Pharmacy and Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
ORCID-Profile: Yiyuan Tian, Menghui Yuan, Wen Huang, Le Yang
Förderung
- This study was supported by the China Postdoctoral Science Foundation funded project (grant 2019M663984 and 2020T130787) and National Science Basic Research Pl…
Zitieren
APA
Tian, Y., Mu, J., Ye, J., Wei, J., Hu, L., Yuan, M., Huang, W., Yang, L., & Yuan, P. (2025). NPAS2 Deficiency Leads to Antidepressant‐Like Behaviors in Mice by Modulating Astrocyte‐Mediated Neuroinflammation. Journal of Pineal Research. https://doi.org/10.1111/jpi.70070
Vancouver
Tian Y, Mu J, Ye J, Wei J, Hu L, Yuan M, et al. NPAS2 Deficiency Leads to Antidepressant‐Like Behaviors in Mice by Modulating Astrocyte‐Mediated Neuroinflammation. Journal of Pineal Research. 2025. doi:10.1111/jpi.70070
BibTeX
@article{Tian2025,
author = {Tian, Yiyuan and Mu, Jiao and Ye, Jiali and Wei, Jingyi and Hu, Longquan and Yuan, Menghui and Huang, Wen and Yang, Le and Yuan, Peng},
title = {NPAS2 Deficiency Leads to Antidepressant‐Like Behaviors in Mice by Modulating Astrocyte‐Mediated Neuroinflammation},
journal = {Journal of Pineal Research},
year = {2025},
doi = {10.1111/jpi.70070}
}
EUVIMED